According to KOBAYASHI Pharmaceutical's latest financial reports the company has $0.63 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.79 B | -15.7% |
2021-12-31 | $0.94 B | 3.59% |
2020-12-31 | $0.91 B | 9.99% |
2019-12-31 | $0.83 B | 10.89% |
2018-12-31 | $0.75 B | 15.31% |
2017-12-31 | $0.65 B | |
2016-03-31 | $0.58 B | 11.86% |
2015-03-31 | $0.52 B | -2.68% |
2014-03-31 | $0.53 B | 7.27% |
2013-03-31 | $0.50 B | -22.67% |
2012-03-31 | $0.64 B | 25.72% |
2011-03-31 | $0.51 B | 13.24% |
2010-03-31 | $0.45 B | 56.74% |
2009-03-31 | $0.29 B | 26.6% |
2008-03-31 | $0.22 B | 23.74% |
2007-03-31 | $0.18 B | -15.62% |
2006-03-31 | $0.22 B | 17.79% |
2005-03-31 | $0.18 B |